Homepage  
SymptomsDiseasesGenetestsShipmentSampleContactQuality
   
 


Pseudohypoaldosteronism
177735
264350
145260


Pedigree


Diagnostic
strategy


Forms


Print page


Sprache
wechseln

Pseudohypoaldosteronism

Clinical feature: 

Definition: Pseudohypoaldosteronisms is characterized by metabolic acidosis and hyperkalemia as a result of kidney's inability to respond adequatly to aldosterone.

Clinical picture: Besides metabolic acidosis and hyperkalimia, which are common to all types of pseudohypoaldosteronism, there are symptoms that vary. These symptoms are hypertension, plasma renin and aldosterone levels, as well as the type of inheritance (autosomal recessive or dominant).
The therapy also differs according to the underlying mutation.

Diagnostics: 

Diagnosis: Verify a genetic origin by thoroughly excluding toxic tubulus damage or abuse of amiloride and triamterene. Reliable plasma renin and aldosterone levels and the type of inheritance allows to determine the subtype. This can significantly reduce time and cost, when undertaking molecular genetic analysis.

Differential: The primary hereditary types (1 and 2) of pseudohypoaldosteronism have to be distinguished from type 3, or secondary aldosterone resistance. Massive salt losses through intestine or sweat seldom cause this form of pseudohypoaldosteronism. More often renal diseases are involved, such as obstructive uropathy, sickle cell and lead nephropathy and amyloidosis.

Systematic link table: 

Disorders of tubular solute transport
Aminoaciduria
Hereditary Salt-wasting tubulopathies
Hyperphosphaturia
Liddle syndrome
NEDD4
NEDD4L
NR3C2
SCNN1B
SCNN1G
Lowe disease
OCRL1
Monosacchariduria
Nephrogenic diabetes insipidus
AQP2
AVPR2
Pseudohypoaldosteronism
Pseudohypoaldosteronism type 2
WNK1
WNK4
Pseudohypoaldosteronism type1
NR3C2
SCNN1A
SCNN1B
SCNN1G
Renal Hypouricemia
SLC22A12
Renal tubular acidosis
ATP6V0A4
ATP6V1B1
CA2
SLC4A1
SLC4A4

Literature: 

Bonny O et al. (2002) Disturbances of Na/K balance: pseudohypoaldosteronism revisited.
Luft FC et al. (2003) Mendelian forms of human hypertension and mechanisms of disease.
Geller DS et al. (2005) Mineralocorticoid resistance.